ChecklistTo be completed by Applicant(1) Certificate in respect of Imported Drugs Completed Application FormTRINIDAD AND TOBAGOMINISTRY OF HEALTHCHEMISTRY/FOOD AND DRUGS DIVISIONDETAILED OF REQUIREMENTS FOR NEW DRUG SUBMISSIONFree Sale Certificate - Original, Apostille and Attested1.1. Certificate of Free Sale Issued by the Drug Regulatory Authority of the Manufacturing Country or Exporting Country.a) Brand name of the product (if any)b) Generic name (INN) of the active ingredient(s)c) Dosage strength and dosage <strong>form</strong>d) Complete name and address of the manufacturere) A statement that the product is freely sold in the country of origin.or Certificate of Pharmaceutical Product - Original, Apostille and Attested1.2 Issued in accordance with the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving inInternational Commerce (CPP). It applies to the case of imported medicines, as it is the certificate issued by the NationalRegulatory Authority (NRA) that issues the registration. This certificate also attests to the Good Manufacturing Practices(GMP) of the manufacturing laboratory(ies).(2) Chemical Documentation(A) Finished Product2.A.1 Specifications(a) Provide a complete description of the quality indexes or specifications(physical, chemical, and microbiological) and acceptable limits in table<strong>form</strong>at, independently of the methods of analysis and quality reference(reference pharmacopeia or manufacturer);(b) Justify any omission of the quality indexes established in the referencePharmacopoeias for the product whose registration is being requested;(c) All solid <strong>form</strong>s of controlled or modified release (tablets, capsules, ovules)require time-release testing.2.A.2 Method of Analysis(a) Provide in<strong>form</strong>ation on the methods of analysis used for quality control: A specific monograph, when from a reference pharmacopeia; A complete description of the method of analysis, when fromthe manufacturer.2
2.A3 Certificate of Analysis - Original(a) Include a certificate with evidence of the quality specifications issuedby the manufacturer of the finished product. In the case of initialproduction of products in development, it is acceptable that the testswere conducted in pilot batches.2.A4 Stability DataSubmit the stability study, including the following:a) Study protocol:b) Quality specifications and methods of analysis;c) Detailed description of the container closing system usedwith the product being evaluated;d) Storage conditions (temperature, light sensitivity and relativehumidity in the environment);e) Results from at least three lots of the finished product (usingpreferably different lots of the Active Pharmaceutical Ingredient);f) Conclusions and proposed expiration date and storage conditions;g) The professional responsible for the study should sign off on thestability studies;h) When the dosage <strong>form</strong> of the medicine is accompanied by a solventor diluents, include stability studies on the diluted, dissolved or dispersedproduct, as applicable, in the conditions under which it s to be utilized;i) If more than one vehicle is used for its preparation, submit data from thestability studies conducted for each of them;j) If a product is packaged in two or more container closing systems, presentthe stability studies for each of them.k) If a product is packaged in two or more volumes, stability studies have to bepresented according to international regulations in force.l) It is required the <strong>submission</strong> of accelerated studies and long term (shelf-lifeor shelf-life only.2.A.5 Disintegrationa) Equipment and apparatus required;b) Test parameters;c) Test medium;d) Specification.2.A.6 Dissolution Profilea) Equipment and apparatus required;b) List of chemical/reagents required;c) Test parameters i.e. type and volume of dissolution medium, rotationrate, temperature of solution and timed) Preparation of dissolution medium, preparation of sample andstandard solution (if any), etc.e) Type and method of analysis (HPLC, UV, etc) and test procedures.For example, if HPLC method is used, test method has to includethe preparation of mobile phase, brand and type of column used, runtime, detector used (UV, RI, etc), injection volume, system suitabilitytest and other parameters.f) Typical chromatograms/UV spectrum for sample & standardsolution, system suitability etcg) Complete <strong>form</strong>ula for calculation. For example, „slow release‟products calculation must include quantity of active substance in themedium volume which has been taken out for analysis.3